Kee Song Bio-Technology Holdings Limited announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 633.927 million compared to TWD 698.923 million a year ago. Operating income was TWD 33.219 million compared to operating loss of TWD 76.952 million a year ago. Net income was TWD 33.770 million compared to net loss of TWD 43.434 million a year ago. Basic earnings per share was TWD 0.91 compared to basic loss per share of TWD 1.18 a year ago. For the half year, sales was TWD 1,354.973 million compared to TWD 1,481.514 million a year ago. Operating loss was TWD 12.739 million compared to TWD 80.059 million a year ago. Net loss was TWD 23.082 million compared to TWD 58.071 million a year ago. Basic loss per share was TWD 0.63 compared to TWD 1.58 a year ago.